Modern Africa Today
SEE OTHER BRANDS

Your daily news update on Africa

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on June 2, 2025

2025: New Launch of the Compliant Cloud Mining Platform Driving Next-Gen Tech and Market Leadership

2025: New Launch of the Compliant Cloud Mining Platform Driving Next-Gen Tech and Market Leadership

Salford, Greater Manchester, England, June 02, 2025 (GLOBE NEWSWIRE) -- Global Cloud Mining proudly announces the rollout of its state-of-the-art Compliant Cloud Mining Platform, designed to set a new benchmark in cryptocurrency mining by fully aligning …

Under the Bitcoin Rally Wave, KixaMiner Unveils Your Journey to Efficient and Stable Passive Bitcoin Earnings

Under the Bitcoin Rally Wave, KixaMiner Unveils Your Journey to Efficient and Stable Passive Bitcoin Earnings

London, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market ushers in another upsurge and Bitcoin prices hit new highs, KixaMiner, an innovator in the cloud mining sector, is building a fast track to digital asset wealth for …

ZA Miner Announces Strategic Investment to Revolutionize AI-Powered Cloud Mining with Global Green Expansion

ZA Miner Announces Strategic Investment to Revolutionize AI-Powered Cloud Mining with Global Green Expansion

London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- ZA Miner, a trailblazer in cloud-based cryptocurrency mining, has officially announced a significant round of strategic investment aimed at scaling its cutting-edge AI-integrated mining infrastructure. This …

Luxren Capital Introduces a New Era in Mobile Trading: Secure, Regulated, and Always at Users' Fingertips

Luxren Capital Introduces a New Era in Mobile Trading: Secure, Regulated, and Always at Users' Fingertips

PORT LOUIS, MAURITIUS, June 02, 2025 (GLOBE NEWSWIRE) -- As more and more people across the world want flexible and fast-paced financial services, Luxren Capital is making a bold move by launching its innovative mobile trading platform. This platform is …

Century Applauds President Trump’s Aluminum Tariff Increase

Century Applauds President Trump’s Aluminum Tariff Increase

CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) applauds President Trump’s unwavering defense of the nation’s domestic production of critical metals by increasing aluminum tariffs to 50 percent. President Trump’s action, …

IFEX Capital Introduces Its Latest Version of a Groundbreaking Trading Platform Connecting Traders Globally

IFEX Capital Introduces Its Latest Version of a Groundbreaking Trading Platform Connecting Traders Globally

PORT LOUIS, MAURITIUS, June 02, 2025 (GLOBE NEWSWIRE) -- IFEX Capital recently introduced a major leap forward in trading technology, setting new standards for reliability and lightning-fast execution with its recent platform updates. IFEX Capital's latest …

High Grade Ni/PGE Adjoining Globex’s Tyrone Property

High Grade Ni/PGE Adjoining Globex’s Tyrone Property

ROUYN-NORANDA, Quebec, June 02, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma

TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or bispecific therapies (84%) as well as …

Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update

Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response (DDR) cancer therapies powered by artificial …

Robex Reports Operational and Financial Results for Q1 2025

Robex Reports Operational and Financial Results for Q1 2025

QUÉBEC CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX/ASX: RXR) Matthew Wilcox, Managing Director, commented: "The company has had a strong start to 2025, construction continues to advance at Kiniero, and …

Fancamp Announces Appointment of CIO

Fancamp Announces Appointment of CIO

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce the appointment of Mr. Kit Spring to the position of Chief Investment Officer (“CIO …

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting

31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …

Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML

Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML

Presentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June 21 SIDNEY is an ongoing Phase 2 trial of EO2463 in 48   indolent Non-Hodgkin Lymphoma (iNHL) patients Enterome has held a positive Type-C meeting with FDA for …

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting

- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …

Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors

Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), is pleased to announce that Mr. Michael Mulberry has been appointed to the board of directors of the …

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Median overall survival data in first-line recurrent/metastatic (1L r/m) HNSCC remains durable at 30.0 months with additional follow-up of ~4.5 months beyond the initial abstract HPV16-positive is the most rapidly increasing HNSCC in the US VERSATILE-003 …

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting

Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a …

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will …

Amerigo Announces Board Appointment

Amerigo Announces Board Appointment

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) is pleased to announce the appointment of Ignacio Cruz to the Company’s board of directors. Ignacio Cruz is a Civil …

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

WILMINGTON, Del., June 02, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June. …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service